The thioredoxin system in retroviral infection and apoptosis

被引:91
作者
Masutani, H
Ueda, S
Yodoi, J
机构
[1] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Thioredoxin Project,Sakyo Ku, Kyoto 606, Japan
关键词
thioredoxin; thioredoxin-binding protein-2 (TBP-2)/vitamin D-3 upregulated protein-1 (VDUP1); apoptosis; apoptosis signal-regulating kinase 1 (ASK1); HIV; HTLV-I;
D O I
10.1038/sj.cdd.4401625
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human thioredoxin (TRX) was first identified in human T-cell leukemia virus type I (HTLV-I)-positive T-cell lines and is associated with the pathophysiology of retroviral infections. TRX is a vital component of the thiol-reducing system and regulates various cellular function ( redox regulation). Members of the TRX system regulate apoptosis through a wide variety of mechanisms. A family of thioredoxin-dependent peroxidases (peroxiredoxins) protects against apoptosis by scavenging hydrogen peroxide. Thioredoxin 2 is a critical regulator of cytochrome c release and mitochondrial apoptosis; transmembrane thioredoxin-related molecule (TMX) has a protective role in endoplasmic reticulum ( ER) stress-induced apoptosis. TRX interacts with apoptosis signal-regulating kinase 1 (ASK1) and is a sensor of oxidative stress. Thioredoxin binding protein-2/vitamin D-3 upregulated protein 1 is a growth suppressor and its expression is suppressed in HTLV-I-transformed cells. Studies of these molecules of the TRX system provide novel insights into the apoptosis associated with retroviral diseases.
引用
收藏
页码:991 / 998
页数:8
相关论文
共 93 条
[41]   Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c [J].
Liu, XS ;
Kim, CN ;
Yang, J ;
Jemmerson, R ;
Wang, XD .
CELL, 1996, 86 (01) :147-157
[42]   Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor [J].
Loeffler, M ;
Daugas, E ;
Susin, SA ;
Zamzami, N ;
Métivier, D ;
Nieminen, AL ;
Brothers, G ;
Penninger, JM ;
Kroemer, G .
FASEB JOURNAL, 2001, 15 (03) :758-767
[43]  
MAEDA M, 1987, BLOOD, V70, P1407
[44]  
MAKINO S, 1992, IMMUNOLOGY, V76, P578
[45]   Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax [J].
Masutani, H ;
Hirota, K ;
Sasada, T ;
UedaTaniguchi, Y ;
Taniguchi, Y ;
Sono, H ;
Yodoi, J .
IMMUNOLOGY LETTERS, 1996, 54 (2-3) :67-71
[46]   DYSREGULATION OF ADULT T-CELL LEUKEMIA-DERIVED FACTOR (ADF) THIOREDOXIN IN HIV-INFECTION - LOSS OF ADF HIGH-PRODUCER CELLS IN LYMPHOID-TISSUES OF AIDS PATIENTS [J].
MASUTANI, H ;
NAITO, M ;
TAKAHASHI, K ;
HATTORI, T ;
KOITO, A ;
TAKATSUKI, K ;
GO, T ;
NAKAMURA, H ;
FUJII, S ;
YOSHIDA, Y ;
OKUMA, M ;
YODOI, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (09) :1707-1715
[47]  
Masutani H, 2002, METHOD ENZYMOL, V347, P279
[48]   Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene [J].
Matsui, M ;
Oshima, M ;
Oshima, H ;
Takaku, K ;
Maruyama, T ;
Yodoi, J ;
Taketo, MM .
DEVELOPMENTAL BIOLOGY, 1996, 178 (01) :179-185
[49]   TMX, a human transmembrane oxidoreductase of the thioredoxin family: the possible role in disulfide-linked protein folding in the endoplasmic reticulum [J].
Matsuo, Y ;
Nishinaka, Y ;
Suzuki, S ;
Kojima, M ;
Kizaka-Kondoh, S ;
Kondo, N ;
Son, A ;
Sakakura-Nishiyama, J ;
Yamaguchi, Y ;
Masutani, H ;
Ishii, Y ;
Yodoi, J .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 423 (01) :81-87
[50]   Identification of a novel thioredoxin-related transmembrane protein [J].
Matsuo, Y ;
Akiyama, N ;
Nakamura, H ;
Yodoi, J ;
Noda, M ;
Kizaka-Kondoh, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10032-10038